Mollenhauer, Brit

[["dc.bibliographiccitation.firstpage","24"],["dc.bibliographiccitation.journal","Parkinsonism & Related Disorders"],["dc.bibliographiccitation.lastpage","26"],["dc.bibliographiccitation.volume","75"],["dc.contributor.author","Hopfner, Franziska"],["dc.contributor.author","Mueller, Stefanie H."],["dc.contributor.author","Szymczak, Silke"],["dc.contributor.author","Junge, Olaf"],["dc.contributor.author","Tittmann, Lukas"],["dc.contributor.author","May, Sandra"],["dc.contributor.author","Lohmann, Katja"],["dc.contributor.author","Grallert, Harald"],["dc.contributor.author","Lieb, Wolfgang"],["dc.contributor.author","Strauch, Konstantin"],["dc.contributor.author","Müller-Nurasyid, Martina"],["dc.contributor.author","Berger, Klaus"],["dc.contributor.author","Schormair, Barbara"],["dc.contributor.author","Winkelmann, Juliane"],["dc.contributor.author","Mollenhauer, Brit"],["dc.contributor.author","Trenkwalder, Claudia"],["dc.contributor.author","Maetzler, Walter"],["dc.contributor.author","Berg, Daniela"],["dc.contributor.author","Kasten, Meike"],["dc.contributor.author","Klein, Christine"],["dc.contributor.author","Höglinger, Günter U."],["dc.contributor.author","Gasser, Thomas"],["dc.contributor.author","Deuschl, Günther"],["dc.contributor.author","Franke, André"],["dc.contributor.author","Krawczak, Michael"],["dc.contributor.author","Dempfle, Astrid"],["dc.contributor.author","Kuhlenbäumer, Gregor"],["dc.date.accessioned","2021-04-14T08:25:55Z"],["dc.date.available","2021-04-14T08:25:55Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1016/j.parkreldis.2020.05.003"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/81769"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.issn","1353-8020"],["dc.title","Private variants in PRKN are associated with late-onset Parkinson's disease"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","1512.e1"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Neurobiology of Aging"],["dc.bibliographiccitation.volume","35"],["dc.contributor.author","Koschmidder, Eva"],["dc.contributor.author","Mollenhauer, Brit"],["dc.contributor.author","Kasten, Meike"],["dc.contributor.author","Klein, Christine"],["dc.contributor.author","Lohmann, Katja"],["dc.date.accessioned","2018-11-07T09:39:54Z"],["dc.date.available","2018-11-07T09:39:54Z"],["dc.date.issued","2014"],["dc.description.abstract","VPS35 mutations have been identified as a cause of autosomal dominantly inherited Parkinson's disease (PD). VPS35 interacts with VPS26A in the retromer complex that links mitochondrial and lysosomal pathways, which have both been shown to be dysfunctional in PD. Thus, mutations in VPS26A may be associated with PD. To test this hypothesis, we screened 245 idiopathic PD patients and 185 control subjects for mutations in the retromer subunit VPS26A. We found 2 novel missense variants in patients and 2 known missense variants in control subjects. The missense variants were unlikely to be disease causing, suggesting that VPS26A mutations are not a frequent cause of PD. (C) 2014 Elsevier Inc. All rights reserved."],["dc.identifier.doi","10.1016/j.neurobiolaging.2013.12.016"],["dc.identifier.isi","000333970800037"],["dc.identifier.pmid","24417787"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/33396"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Inc"],["dc.relation.issn","1558-1497"],["dc.relation.issn","0197-4580"],["dc.title","Mutations in VPS26A are not a frequent cause of Parkinson's disease"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1245"],["dc.bibliographiccitation.issue","7"],["dc.bibliographiccitation.journal","Movement Disorders"],["dc.bibliographiccitation.lastpage","1248"],["dc.bibliographiccitation.volume","35"],["dc.contributor.author","Hopfner, Franziska"],["dc.contributor.author","Mueller, Stefanie H."],["dc.contributor.author","Szymczak, Silke"],["dc.contributor.author","Junge, Olaf"],["dc.contributor.author","Tittmann, Lukas"],["dc.contributor.author","May, Sandra"],["dc.contributor.author","Lohmann, Katja"],["dc.contributor.author","Grallert, Harald"],["dc.contributor.author","Lieb, Wolfgang"],["dc.contributor.author","Strauch, Konstantin"],["dc.contributor.author","Müller‐Nurasyid, Martina"],["dc.contributor.author","Berger, Klaus"],["dc.contributor.author","Schormair, Barbara"],["dc.contributor.author","Winkelmann, Juliane"],["dc.contributor.author","Mollenhauer, Brit"],["dc.contributor.author","Trenkwalder, Claudia"],["dc.contributor.author","Maetzler, Walter"],["dc.contributor.author","Berg, Daniela"],["dc.contributor.author","Kasten, Meike"],["dc.contributor.author","Klein, Christine"],["dc.contributor.author","Höglinger, Günter U."],["dc.contributor.author","Gasser, Thomas"],["dc.contributor.author","Deuschl, Günther"],["dc.contributor.author","Franke, André"],["dc.contributor.author","Krawczak, Michael"],["dc.contributor.author","Dempfle, Astrid"],["dc.contributor.author","Kuhlenbäumer, Gregor"],["dc.date.accessioned","2021-04-14T08:26:16Z"],["dc.date.available","2021-04-14T08:26:16Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1002/mds.28037"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/81882"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1531-8257"],["dc.relation.issn","0885-3185"],["dc.title","Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","282"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Neuroepidemiology"],["dc.bibliographiccitation.lastpage","297"],["dc.bibliographiccitation.volume","45"],["dc.contributor.author","Lerche, Stefanie"],["dc.contributor.author","Liepelt-Scarfone, Inga"],["dc.contributor.author","Alves, Guido"],["dc.contributor.author","Barone, Paolo"],["dc.contributor.author","Behnke, Stefanie"],["dc.contributor.author","Ben-Shlomo, Yoav"],["dc.contributor.author","Berendse, Henk W."],["dc.contributor.author","Burns, David J."],["dc.contributor.author","Dodel, Richard"],["dc.contributor.author","Grosset, Donald G."],["dc.contributor.author","Heinzel, Sebastian"],["dc.contributor.author","Hu, Michele T. M."],["dc.contributor.author","Kasten, Meike"],["dc.contributor.author","Krueger, Rejko"],["dc.contributor.author","Maetzler, Walter"],["dc.contributor.author","Moccia, Marcello"],["dc.contributor.author","Mollenhauer, Brit"],["dc.contributor.author","Oertel, Wolfgang"],["dc.contributor.author","Roeben, Benjamin"],["dc.contributor.author","Suenkel, Ulrike"],["dc.contributor.author","Walter, Uwe"],["dc.contributor.author","Wirdefeldt, Karin"],["dc.contributor.author","Berg, Daniela"],["dc.date.accessioned","2018-11-07T10:02:39Z"],["dc.date.available","2018-11-07T10:02:39Z"],["dc.date.issued","2015"],["dc.description.abstract","Background: Enormous effort is being put into the identification and characterization of symptoms that may be used as predictive and progression markers in Parkinson's disease (PD). An impressive number of PD patients and individuals at risk for or in the prodromal stage of PD are currently followed in longitudinal studies; however, there does not exist an overview on the kind of markers evaluated and the assessments used. Methods: Information on the design, sample size, evaluated markers and assessments of 21 studies of the Joint Programme - Neurodegenerative Disease Research BioLoC-PD working group were collected by questionnaire. The studies were classified into at risk/prodromal or clinical PD cohorts. The assessments were grouped into quantitative assessments, investigator-rated assessments, investigator inter-views, patient-rated questionnaires and caregiver-rated questionnaires. Results: Compilation of these data revealed an interesting consensus on evaluated markers, but there was an enormous variability of assessments. Furthermore, there is a remarkable similarity in the markers assessed and evaluation methods applied in the risk/prodromal and clinical PD cohorts. Conclusions: The inventory of the longitudinal cohorts that are part of the BioLoC-PD consortium reveals that there is a growing consensus on the markers that should be assessed in longitudinal cohort studies in PD. However, controversy still exists on the specific type of assessment. To allow comparison of data and common analyses it will be essential to harmonize scales and assessment outcomes. (C) 2015 S. Karger AG, Basel"],["dc.identifier.doi","10.1159/000439221"],["dc.identifier.isi","000366276700006"],["dc.identifier.pmid","26523894"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/38272"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Karger"],["dc.relation.issn","1423-0208"],["dc.relation.issn","0251-5350"],["dc.title","Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]